Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla® Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla® Agreement enables expanded patient access of the only EU-approved treatment for myotonia symptoms in non-dystrophic myotonic...

Lupin signs distribution agreements in key EU territories for orphan drug NaMuscla® Lupin signs distribution agreements in key EU territories for orphan drug NaMuscla®Enables expanded patient access of rare disease medicine to treat myotonia symptoms in non-dystrophic myotonic...